PracticeConsultingFD to quit cloning company

FD to quit cloning company

PPL Therapeutics, the company that cloned Dolly the Sheep, is to set to lose its finance director following a management shake-up.

The company announced FD Richard Cruse would leave by the end of the year with the search for a replacement starting immediately.

The boardroom restructuring, which followed the announcement of a £32m rights issue, will also see the departure of Ron James, managing director of PPL.

Earlier in the year, PPL failed in an attempted £40m fundraising, but succeeded this time after Deutsche Bank agreed to underwrite the issue.

Without the new funds, the company would have run out of cash by the end of the year.

In a statement, the company said: ‘With the progress of PPL from its research-based origins towards being an organisation with a manufacturing capability and products on the market, the board now considers it is appropriate to review its composition to ensure that the senior management of the group is able to fulfil the objectives of the group going forward.’

The company is pinning its future hopes on AAT, a protein for treating emphysema, which it hopes to bring to the market by 2005.

Links

PPL Therapeutics website

Related Articles

5 tips for SMEs to protect cash flow

Accounting Software 5 tips for SMEs to protect cash flow

3m Alia Shoaib, Reporter
Tyrie on Finance Bill 2017: ‘Making Tax Policy Better’

Consulting Tyrie on Finance Bill 2017: ‘Making Tax Policy Better’

9m Stephanie Wix, Writer
Managing partner Q&A - the year ahead: Richard Toone, CVR Global

Accounting Firms Managing partner Q&A - the year ahead: Richard Toone, CVR Global

10m Kevin Reed, Writer
Friday Afternoon Live: HMRC complaints rise; Deloitte scoops big audits; and corporate reporting woes

Audit Friday Afternoon Live: HMRC complaints rise; Deloitte scoops big audits; and corporate reporting woes

11m Kevin Reed, Writer
New head of equity capital markets for KPMG

Accounting Firms New head of equity capital markets for KPMG

11m Stephanie Wix, Writer
Deloitte 'self-imposes exile' on government contracts to defuse PM row

Accounting Firms Deloitte 'self-imposes exile' on government contracts to defuse PM row

10m Kevin Reed, Writer
Managing partner Q&A - the year ahead: Julie Adams, Menzies

Accounting Firms Managing partner Q&A - the year ahead: Julie Adams, Menzies

10m Kevin Reed, Writer
Friday Afternoon Live: Deloitte's tech thing; PAC wants HMRC 'contingencies'; and Sports Direct

Business Regulation Friday Afternoon Live: Deloitte's tech thing; PAC wants HMRC 'contingencies'; and Sports Direct

10m Kevin Reed, Writer